Share on StockTwits

Medtronic (NYSE:MDT) is scheduled to be issuing its Q414 quarterly earnings data on Tuesday, May 20th. Analysts expect the company to announce earnings of $1.12 per share and revenue of $4.58 billion for the quarter. Medtronic has set its FY14 guidance at $3.81-3.83 EPS.Persons that are interested in registering for the company’s earnings conference call can do so using this link.

Medtronic (NYSE:MDT) last released its earnings data on Tuesday, February 18th. The company reported $0.91 EPS for the quarter, meeting the Thomson Reuters consensus estimate of $0.91. The company had revenue of $4.20 billion for the quarter, compared to the consensus estimate of $4.15 billion. On average, analysts expect Medtronic to post $3.82 EPS for the current fiscal year and $4.09 EPS for the next fiscal year.

Shares of Medtronic (NYSE:MDT) opened at 60.39 on Monday. Medtronic has a one year low of $49.59 and a one year high of $62.90. The stock has a 50-day moving average of $59.7 and a 200-day moving average of $58.33. The company has a market cap of $60.439 billion and a price-to-earnings ratio of 17.02.

MDT has been the subject of a number of recent research reports. Analysts at Deutsche Bank reiterated a “buy” rating on shares of Medtronic in a research note on Tuesday, April 22nd. They now have a $58.94 price target on the stock. Finally, analysts at Bank of America reiterated a “buy” rating on shares of Medtronic in a research note on Monday, April 14th. They now have a $66.00 price target on the stock. Eight analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. The stock currently has an average rating of “Buy” and an average target price of $62.44.

Medtronic, Inc (NYSE:MDT) is engaged in medical technology – alleviating pain, restoring health, and extending life for millions of people worldwide.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.